Company Filing History:
Years Active: 2017-2025
Title: Michael Baltezor: Innovator in Therapeutic Methods
Introduction: Michael Baltezor, based in Lawrence, KS, is a notable inventor with a focus on groundbreaking therapeutic methods. With an impressive portfolio of 20 patents, he has made significant contributions to the medical field, particularly in oncology treatments.
Latest Patents: Among his latest innovations, Baltezor has developed a method for treating epithelial cysts, including pancreatic cysts, through intracystic injection of antineoplastic particles. This method utilizes compositions comprising taxane particles such as paclitaxel and docetaxel, showcasing his commitment to advancing cancer treatments. Additionally, he has patented particles of lapatinib, a targeted cancer therapy, which are formulated to achieve specific surface area and particle size for enhanced delivery and efficacy.
Career Highlights: Baltezor's career is marked by his work at Crititech, Inc., where he applies his expertise in the development of innovative therapeutic solutions. His contributions have positioned him as a leader in the research and application of targeted cancer therapies, further highlighting his dedication to improving patient outcomes.
Collaborations: Throughout his career, Baltezor has collaborated with fellow innovators such as Matthew McClorey and Joseph S. Farthing. These partnerships have enriched his research endeavors and fostered an environment of creativity and innovation within the medical community.
Conclusion: Michael Baltezor stands out as a significant figure in the field of cancer treatment innovations. His visionary work at Crititech, Inc., along with his extensive patent portfolio, reflects a deep commitment to finding effective solutions for challenging medical issues. As he continues to innovate, Baltezor's contributions will undoubtedly leave a lasting impact on the healthcare landscape.